Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
ACADIA Pharmaceuticals Inc. (ACAD) had Normalized Pre-Tax Income of $80.44M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$342.29M |
|
$53.52M |
|
$35.09M |
|
$307.20M |
|
$270.57M |
|
$71.72M |
|
$8.72M |
|
$80.44M |
|
|
Normalized Pre-Tax Income |
$80.44M |
$53.52M |
|
$53.52M |
|
$53.52M |
|
$53.52M |
|
$71.72M |
|
$75.23M |
|
172.54M |
|
175.47M |
|
$0.31 |
|
$0.31 |
|
| Balance Sheet Financials | |
$1.27B |
|
$18.40M |
|
$525.73M |
|
$1.79B |
|
$332.22M |
|
-- |
|
$74.44M |
|
$406.66M |
|
$1.39B |
|
$1.25B |
|
$1.39B |
|
172.79M |
|
| Cash Flow Statement Financials | |
$146.26M |
|
$-28.40M |
|
$26.60M |
|
$185.54M |
|
$330.21M |
|
$144.67M |
|
$49.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
89.75% |
|
20.95% |
|
20.95% |
|
-- |
|
23.50% |
|
15.64% |
|
$134.72M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
0.87 |
|
1.92 |
|
46.89 |
|
3.86% |
|
4.28% |
|
2.98% |
|
3.86% |
|
$8.03 |
|
$0.77 |
|
$0.83 |
|